Optina Diagnostics Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
22
- Latest Deal Type
-
Later Stage VC
- Investors
-
21
Optina Diagnostics General Information
Description
Developer of ocular imaging systems and diagnostic technology designed to help detect key biomarkers of Alzheimer's disease. The company's platform combines data-rich images with AI imaging systems to detect age-related macular degeneration and ocular diabetic retinopathy and identify beta-amyloid plaques, enabling doctors to treat the cause of memory loss through a simple eye exam.
Contact Information
Website
www.optinadx.comCorporate Office
- 8200 Decarie Boulevard
- Suite 220
- Montreal, Quebec H4P 2P5
- Canada
Corporate Office
- 8200 Decarie Boulevard
- Suite 220
- Montreal, Quebec H4P 2P5
- Canada
Optina Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Later Stage VC | 01-Jan-2023 | Completed | Generating Revenue | |||
| 13. Later Stage VC | 24-Jan-2022 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series A) | 28-Oct-2021 | Completed | Generating Revenue | |||
| 10. Later Stage VC | 20-Jun-2020 | Completed | Generating Revenue | |||
| 9. Later Stage VC | 12-Jun-2019 | Completed | Generating Revenue | |||
| 8. Seed Round | 10-Oct-2018 | Completed | Clinical Trials - Phase 3 | |||
| 7. Accelerator/Incubator | 22-Jan-2018 | Completed | Clinical Trials - Phase 3 | |||
| 6. Debt - General | 31-Dec-2017 | $114K | $303K | Completed | Startup | |
| 5. Accelerator/Incubator | 01-Jan-2017 | $190K | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Optina Diagnostics Comparisons
Industry
Financing
Details
Optina Diagnostics Competitors (2)
One of Optina Diagnostics’s 2 competitors is Nucleix, a Venture Capital-Backed company based in Rehovot, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nucleix | Venture Capital-Backed | Rehovot, Israel | ||||
| ROCA Test | Formerly VC-backed | Cambridge, United Kingdom |
Optina Diagnostics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Optina Diagnostics Patents
Optina Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025158396-A1 | Systems and methods for generating spectral and spatial gradient images of biological tissue | Pending | 26-Jan-2024 | ||
| WO-2025078936-A1 | Method and system for mapping biological structures indicative of a medical condition from a multispectral retinal image | Inactive | 08-Oct-2023 | ||
| WO-2025078935-A1 | Normalizing hyper- and multi-spectral retinal images to isolate spectral contribution of retinal features | Inactive | 08-Oct-2023 | ||
| US-20260094273-A1 | Retinal image data correction for multi- and hyper-spectral cubes | Pending | 03-Apr-2023 | ||
| WO-2024209349-A1 | Retinal image data correction for multi-and hyper-spectral cubes | Inactive | 03-Apr-2023 | G16H30/40 |
Optina Diagnostics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Optina Diagnostics Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alfin Ventures | Venture Capital | Minority | ||
| CABHI | Corporate Venture Capital | Minority | ||
| Alzheimers Drug Discovery Foundation | Not-For-Profit Venture Capital | Minority | ||
| Keihanna Global Acceleration Program | Accelerator/Incubator | |||
| Alfin Asset Management | Asset Manager | Minority |
Optina Diagnostics FAQs
-
When was Optina Diagnostics founded?
Optina Diagnostics was founded in 2011.
-
Where is Optina Diagnostics headquartered?
Optina Diagnostics is headquartered in Montreal, Canada.
-
What is the size of Optina Diagnostics?
Optina Diagnostics has 22 total employees.
-
What industry is Optina Diagnostics in?
Optina Diagnostics’s primary industry is Decision/Risk Analysis.
-
Is Optina Diagnostics a private or public company?
Optina Diagnostics is a Private company.
-
What is Optina Diagnostics’s current revenue?
The current revenue for Optina Diagnostics is .
-
How much funding has Optina Diagnostics raised over time?
Optina Diagnostics has raised $33.4M.
-
Who are Optina Diagnostics’s investors?
Alfin Ventures, CABHI, Alzheimers Drug Discovery Foundation, Keihanna Global Acceleration Program, and Alfin Asset Management are 5 of 21 investors who have invested in Optina Diagnostics.
-
Who are Optina Diagnostics’s competitors?
Nucleix and ROCA Test are competitors of Optina Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
